KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd has announced a significant development in its ownership structure, as Rinani Group Bhd becomes a substantial shareholder with a 5.85% stake. This strategic partnership comes at a crucial time for the company, as it shifts its focus towards biopharmaceuticals and pursues growth initiatives.
Rinani Group’s investment has been warmly received by the company’s group executive chairman, Azri Azerai, who stated, “We are excited to have Rinani Group on board as a substantial shareholder. Their involvement will be invaluable as we navigate through our restructuring phase and enter the next chapter of our growth. This partnership presents us with numerous opportunities in the field of life sciences, aligning perfectly with our growth strategy.”
Azri Azerai also emphasized the positive impact of Rinani’s arrival, stating, “This new partnership strengthens our financial standings and enhances our ability to capitalize on the expanding healthcare sector. Together, we are better positioned to deliver sustainable value to our stakeholders.”
Credit: The Star : Business Feed
